Prevalence of Depression and Anxiety in Patients Seeking Medical Care at General Health Care Settings in China
1 other identifier
observational
8,000
1 country
15
Brief Summary
Objectives: Primary: To estimate the prevalence of depression and/or anxiety disorder in outpatients attending the general health care settings in China. Secondary:
- To estimate gender- and age-specific prevalence of depression and/or anxiety disorder in outpatients attending the general health care settings in China.
- To estimate the prevalence of depression and/or anxiety disorder in outpatients attending the general health care settings such as departments of neurology, gastroenterology, cardiology, and gynecology.
- To describe the recognition and treatment rate by treating physicians as depression and/or anxiety for outpatients in the general health care settings in China.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2007
Shorter than P25 for all trials
15 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2007
CompletedFirst Submitted
Initial submission to the registry
May 24, 2007
CompletedFirst Posted
Study publicly available on registry
May 25, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2007
CompletedDecember 6, 2007
December 1, 2007
May 24, 2007
December 4, 2007
Conditions
Eligibility Criteria
You may qualify if:
- Greater than or equal to 18 years.
- Consecutive general internal medical outpatients attending the selected general hospitals in the investigate days(Department of neurology, gastrointestinal, cardiology and gynecology).
- Informed consent obtained for all patients who will undergo a standardized diagnostic assessment by specialized psychiatrists.
You may not qualify if:
- Patients who have been screened on a previous visit.
- Patients who are unable to complete the survey because of mental or physical incapacity.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (15)
Unknown Facility
Beijing, Beijing Municipality, 100034, China
Unknown Facility
Beijing, Beijing Municipality, 100044, China
Unknown Facility
Beijing, Beijing Municipality, 100730, China
Unknown Facility
Guangzhou, Guangdong, 510120, China
Unknown Facility
Guangzhou, Guangdong, 510180, China
Unknown Facility
Guangzhou, Guangdong, 510630, China
Unknown Facility
Changsha, Hunan, 410008, China
Unknown Facility
Changsha, Hunan, 410011, China
Unknown Facility
Changsha, Hunan, 410013, China
Unknown Facility
Shanghai, Shanghai Municipality, 200025, China
Unknown Facility
Shanghai, Shanghai Municipality, 200233, China
Unknown Facility
Shanghai, Shanghai Municipality, 200235, China
Unknown Facility
Chengdu, Sichuan, 610041, China
Unknown Facility
Chengdu, Sichuan, 610072, China
Unknown Facility
Chengdu, Sichuan, 610083, China
Study Officials
- STUDY DIRECTOR
Medical Monitor
Wyeth is now a wholly owned subsidiary of Pfizer
- PRINCIPAL INVESTIGATOR
Trial Manager
For China, medinfo@wyeth.com
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
May 24, 2007
First Posted
May 25, 2007
Study Start
April 1, 2007
Study Completion
July 1, 2007
Last Updated
December 6, 2007
Record last verified: 2007-12